{"id":176293,"date":"2021-03-22T00:00:00","date_gmt":"2021-03-21T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/covid-19-antipyretiques-en-prophylaxie-avant-la-vaccination-aucun-benefice-prouve\/"},"modified":"2026-04-02T19:10:27","modified_gmt":"2026-04-02T17:10:27","slug":"covid-19-antipyretiques-en-prophylaxie-avant-la-vaccination-aucun-benefice-prouve","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/covid-19-antipyretiques-en-prophylaxie-avant-la-vaccination-aucun-benefice-prouve\/","title":{"rendered":"COVID-19: antipyr\u00e9tiques en prophylaxie avant la vaccination ? Aucun b\u00e9n\u00e9fice prouv\u00e9"},"content":{"rendered":"<p>Des lecteurs nous ont demand\u00e9 s\u2019il \u00e9tait utile d&#39;administrer \u00e0 titre prophylactique du parac\u00e9tamol ou d&#39;autres antipyr\u00e9tiques avant ou au moment de la vaccination contre la COVID-19&#x002C; en pr\u00e9vention des sympt\u00f4mes post-vaccinaux.<\/p>\n<ul>\n<li>\n<p>L&#39;administration pr\u00e9ventive d&#39;antipyr\u00e9tiques n&#39;a pas de b\u00e9n\u00e9fice prouv\u00e9 par rapport \u00e0 l\u2019administration en pr\u00e9sence de sympt\u00f4mes. L&#39;effet antipyr\u00e9tique survient rapidement apr\u00e8s la prise du m\u00e9dicament et le b\u00e9n\u00e9fice est seulement symptomatique. Il revient donc au patient d\u2019\u00e9valuer s\u2019il en a besoin.<\/p>\n<\/li>\n<li>\n<p>Dans une \u00e9tude men\u00e9e chez des enfants (<em>The Lancet<\/em>&#x002C; 2009<span class='folia-referentie-note'><strong><sup>1<\/sup><\/strong><\/span>)&#x002C; l&#39;administration prophylactique de parac\u00e9tamol avait r\u00e9duit la r\u00e9ponse anticorps vis \u00e0-vis de certains vaccins (vaccin pneumococcique 10-valent&#x002C; vaccin hexavalent).<span class='folia-referentie-note'><strong><sup>1<\/sup><\/strong><\/span> Sur la base de cette \u00e9tude&#x002C; <em>The Green Book<\/em> (UK)<span class='folia-referentie-note'><strong><sup>2<\/sup><\/strong><\/span> conclut que l&#39;administration \u00e0 titre prophylactique&#x002C; au moment de la vaccination&#x002C; d&#39;antipyr\u00e9tiques tels que le parac\u00e9tamol et l&#39;ibuprof\u00e8ne&#x002C; n&#39;est pas recommand\u00e9e en routine.<\/p>\n<\/li>\n<li>\n<p>Les <em>Centers for Disease Control and Prevention<\/em> (CDC) am\u00e9ricains signalent que l\u2019on ne connait pas encore l\u2019effet que pourrait avoir l&#39;administration d&#39;un antipyr\u00e9tique au moment de la vaccination sur la r\u00e9ponse anticorps aux vaccins Comirnaty\u00ae&#x002C; COVID-19 Vaccine Moderna\u00ae et Janssen COVID-19 Vaccine\u00ae. Les CDC d\u00e9conseillent donc l&#39;administration prophylactique en routine.<span class='folia-referentie-note'><strong><sup>3<\/sup><\/strong><\/span><\/p>\n<\/li>\n<li>\n<p><em>The Green Book<\/em> (UK) rapporte&#x002C; concernant le vaccin COVID-19 AstraZeneca\u00ae&#x002C; que l&#39;administration prophylactique de parac\u00e9tamol n&#39;influence pas la r\u00e9ponse immunitaire au vaccin.<span class='folia-referentie-note'><strong><sup> 4 <\/sup><\/strong><\/span>\u00a0Ceci ne signifie pas toutefois que l&#39;on peut s\u2019attendre \u00e0 un b\u00e9n\u00e9fice quelconque avec l&#39;administration prophylactique.<\/p>\n<\/li>\n<\/ul>\n<p>\u00a0<br \/> En cas d\u2019apparition de fi\u00e8vre ou de c\u00e9phal\u00e9es apr\u00e8s la vaccination&#x002C; on peut avoir recours \u00e0 un antipyr\u00e9tique. Le parac\u00e9tamol est alors \u00e0 privil\u00e9gier\u00a0; l&#39;ibuprof\u00e8ne ou l&#39;acide ac\u00e9tylsalicylique ne sont pas des pr\u00e9parations de premier choix [voir <a href='https:\/\/www.cbip.be\/fr\/chapters\/9?frag=6403'>R\u00e9pertoire&#x002C; chapitre 8.1.<\/a>].<br \/> \u00a0<br \/> <strong>Note: <\/strong>pour tous nos articles relatifs aux m\u00e9dicaments dans la COVID-19: voir les <a href='https:\/\/www.cbip.be\/fr\/gows\/3334'>Actualit\u00e9s COVID-19 <\/a>\u00a0sur notre site Web.<br \/> \u00a0<\/p>\n<h2>Sources sp\u00e9cifiques<\/h2>\n<div class='reference'><span class='folia-referentie-tekst'><span class='folia-referentie-nummer'>1.\u00a0 <\/span>Prymula R&#x002C; Siegrist C-A et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label&#x002C; randomised controlled trials. The Lancet 2009;374:1339-20 (doi: <span class='folia-referentie-link'><a href='https:\/\/doi.org\/10.1016\/S0140-6736(09)61208-3'>https:\/\/doi.org\/10.1016\/S0140-6736(09)61208-3<\/a><\/span>)&#x002C; avec \u00e9ditorial p. 1305-6 (doi: <span class='folia-referentie-link'><a href='https:\/\/doi.org\/10.1016\/S0140-6736(09)61802-X'>https:\/\/doi.org\/10.1016\/S0140-6736(09)61802-X<\/a><\/span><\/span><\/div>\n<div class='reference'><span class='folia-referentie-tekst'><span class='folia-referentie-nummer'>2.\u00a0 <\/span>Public Health England. The green book.<span class='folia-referentie-link'> <a href='https:\/\/www.gov.uk\/government\/publications\/vaccine-safety-and-adverse-events-following-immunisation-the-green-book-chapter-8'>Vaccine safety and adverse events following immunisation: the green book&#x002C; chapter 8<\/a>&#x002C;<\/span> derni\u00e8re mise \u00e0 jour le 20\/05\/13.<\/span><\/div>\n<div class='reference'><span class='folia-referentie-tekst'><span class='folia-referentie-nummer'>3.\u00a0 <\/span>Centers for Disease Control and Prevention (CDC). Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States. <span class='folia-referentie-link'><a href='https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html'>Website CDC<\/a>&#x002C;<\/span> derni\u00e8re mise \u00e0 jour le 05\/03\/21<\/span><\/div>\n<div class='reference'><span class='folia-referentie-tekst'><span class='folia-referentie-nummer'>4.\u00a0<\/span> Public Health England. The green book.<span class='folia-referentie-link'> <a href='https:\/\/www.gov.uk\/government\/publications\/covid-19-the-green-book-chapter-14a'>COVID-19: the green book&#x002C; chapter 14a<\/a><\/span>&#x002C; derni\u00e8re mise \u00e0 jour le 12\/02\/21<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Des lecteurs nous ont demand\u00e9 s\u2019il \u00e9tait utile d&#39;administrer \u00e0  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,31],"tags":[48,20213,20224,20226],"class_list":["post-176293","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2021-fr","tag-actualites-covid-19","tag-import_tags","tag-import_tags-nl","tag-covid-19-update"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=176293"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176293\/revisions"}],"predecessor-version":[{"id":178872,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176293\/revisions\/178872"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=176293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=176293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=176293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}